glp 1 agonist drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mechanism of action of GLP-1
Description
Headache pain was described as 6/10 in severity
In response, industry giants Novo Nordisk and Eli Lilly are making substantial investments to expand their production capabilities
Given similar side effect profiles and the convenience advantage of weekly versus daily dosing, semaglutide has largely superseded liraglutide as the preferred GLP-1 option for most patients
BMJ 360:k872
C.BrubakerP
GLP-1 receptor agonists also slow gastric emptying, reduce appetite through central nervous system pathways, and promote satiety, leading to reduced caloric intake and weight loss
